When the pandemic began, America’s biopharmaceutical companies immediately started to develop solutions to help diagnose, treat and prevent COVID-19 infection. While authorized vaccines provide hope that this pandemic may soon be over, the biopharmaceutical industry is preparing for the next public health emergency. PhRMA′s CEO, Stephen J. Ubl, will share lessons the biopharmaceutical has learned from COVID-19, what allowed the industry to respond so quickly and how we need to plan for future pandemics.
